LUP Statistics
Record
- Title
- Salvage bortezomib-dexamethasone and high-dose melphalan (HDM) and autologous stem cell support (ASCT) in myeloma patients at first relapse after HDM with ASCT. A phase-2 trial.
- Type
- Journal Article
- Publ. year
- 2015
- Author/s
- Gimsing, P; Hjertner, Ø; Abildgaard, N; Andersen, N F et al.
- Department/s
- Division of Hematology and Transfusion Medicine
- In LUP since
- 2016-04-01
Downloads
Total | This Year | This Month |
322 | 5 | 1 |
United States of America ![]() |
![]() |
Germany ![]() |
![]() |
China ![]() |
![]() |
France ![]() |
![]() |
Russian Federation ![]() |
![]() |
United Kingdom of Great Britain and Northern Ireland ![]() |
![]() |
Netherlands (Kingdom of the) ![]() |
![]() |
Canada ![]() |
![]() |
Bulgaria ![]() |
![]() |
Singapore ![]() |
![]() |
Sweden ![]() |
![]() |
Ireland ![]() |
![]() |
India ![]() |
![]() |
Hong Kong (China) ![]() |
![]() |
Nigeria ![]() |
![]() |
Italy ![]() |
![]() |
New Zealand ![]() |
![]() |
Turkiye ![]() |
![]() |
Czechia ![]() |
![]() |
Taiwan (China) ![]() |
![]() |
South Korea ![]() |
![]() |